Home › Cancro del polmone non a piccole cellule › Missouri

Studi clinici su Cancro del polmone non a piccole cellule nello stato di Missouri

86 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi nello stato di Missouri.

Città nello stato di Missouri

Testo ufficiale dello studio (inglese)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Saint Francis Medical Center, Cape Girardeau
Saint Luke's Hospital, Chesterfield
e altri 18

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Saint Francis Medical Center, Cape Girardeau
Parkland Health Center - Farmington, Farmington
Sainte Genevieve County Memorial Hospital, Sainte Genevieve
e altri 2

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07293247

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Washington University School of Medicine in St. Louis, St Louis

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06465069

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Washington University Medicine, St Louis

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06270706

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Washington University School of Medicine ( Site 3279), St Louis

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07513376

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Washington University, School of Medicine, St Louis

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06172478

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Saint Francis Medical Center, Cape Girardeau

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07388524

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

St. Lukes Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06625775

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
University Health Truman Medical Center, Kansas City
Mercy Hospital South, St Louis
e altri 1

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06498635

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Missouri Cancer Associates, Columbia

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07361497

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Missouri Cancer Associates, Columbia

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07361510

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Washington University Center for Advanced Medicine, St Louis

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Washington University School of Medicine - Siteman Cancer Center, St Louis

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06881784

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, St Louis

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07127874

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Missouri Cancer Associates, Columbia

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07144280

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Washington University School Of Medicine, St Louis

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05498428

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Mercy South - David M Sindelar Cancer Center ( Site 0098), St Louis
Mercy Research - David C. Pratt Cancer Center ( Site 0006), St Louis

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06312137

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, St Louis

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06218914

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Washington University, St Louis

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT04981119

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Saint Luke's Hospital of Kansas City, Kansas City
Saint Luke's East Hospital, Lee's Summit

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06758401

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Truman Medical Ctr West, Kansas City
Oncology Hematology Associates, Springfield
Washington University School Of Medicine, St Louis

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Washington University School of Medicine, St Louis

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07154290

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Washington University in St Louis, St Louis

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06667908

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Bridgeton

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06868277

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Missouri Baptist Medical Center, St Louis

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06890598

Pan-tumor MRD Study

Cox Health, Springfield

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06605404

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
e altri 18

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT03191149

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Local Institution - 0498, Kansas City

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06561386

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Kansas City

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06357533

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Washington University School of Medicine, St Louis

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07140016

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Local Institution - 0140, St Louis

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06618287

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

St. Lukes Hosp. of Kansas City /ID# 259940, Kansas City
Hulston Cancer Center /ID# 232226, Springfield

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT04928846

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Missouri Cancer Associates, Columbia
SSM Health Cancer Care - St. Clare, Fenton

In reclutamentoFase 2/3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06712316

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Washington University School of Medicine, St Louis

In reclutamentoFase 2/3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07100080

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Local Institution - 0685, Fenton

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06875310

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Washington University School of Medicine, St Louis

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT06529822

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Bridgeton
Research Site, Kansas City

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT06692738

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical Study Site, Kansas City
Clinical Study Site, St Louis
Clinical Study Site, St Louis

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT06767514

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

Washington University School of Medicine, St Louis

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT06855771

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Washington University, St Louis

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT05267626

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.